Abstract :

Development and validation of RP-HPLC method for simultaneous estimation of Atazanavir and Ritonavir in their combined tablet dosage form. Atazanavir and Ritonavir are antiviral agents used in treatment of HIV. A simple, precise, rapid, accurate and cost-effective high- performance liquid chromatography (HPLC) method was successfully developed and validated for simultaneous estimation of Atazanavir and Ritonavir in their combined tablet dosage form. The selected mobile phase was Methanol: Phosphate Buffer in proportion 65:35 v/v respectively. The optimized columns used are C18 column, Symmetry and Zodiac column. X bridge C18 (4.6×150 mm, 5 µm) particle size was found to be ideal as it gave good peak shape and resolution at 1ml/min flow for Atazanavir and Ritonavir. In this study, the validation of Atazanavir and Ritonavir in API and marketed formulations were performed keeping in accordance with the parameters like system suitability, specificity, linearity, accuracy, precision (reproducibility & repeatability), robustness. The developed stability indicating method is capable for determination of impurities of Atazanavir and Ritonavir in combined tablet dosage form as well as individual dosage forms also. The method has been successfully validated according to ICH guidelines and the results obtained by using RP – HPLC are rapid, accurate and precise. The proposed methods were successfully applied for the analysis of synthetic mixtures and pharmaceutical formulations of Atazanavir and Ritonavir.

---

Keywords :

Atazanavir, Method Development, Ritonavir, RP-HPLC., Validation

---

References :

1. Shethi PD. HPLC- Quantitative analysis of pharmaceutical formulations. 1st Ed. New Delhi:    CBS Publishers & Distributors; 2001: 8-10, 101-103.
2. Kasture AV, Mahadik KR, Wadodkar SG, More HN. Pharmaceutical Analysis: Vol-II. 8th Ed. Pune: Nirali Prakashan; 2002: 48-57.
3. Jeffery GH, Bassett J. Vogel’s textbook of Quantitative Chemical Analysis. 5th Ed. NewYork: John Wiley & Sons Inc; 1991: 217-235.
4. Sharma Instrumental Method of Chemical Analysis. 20th Ed. Meerut: Goel Publishing House; 2001: 54-83.
5. Gabor S. HPLC in pharmaceutical Analysis: Vol. I. 1st Ed. London: CRC Press; 1990:101-
6. Hobart HW, Merritt LL, John AD. Instrumental Methods of Analysis. 7th Ed. New Delhi: CBS Publishers; 1988: 580-610.
7. Prajapati GA. Method development and validation for simultaneous estimation of Hypertensive drugs by RP-HPLC. M. Pharm Thesis, Maliba Pharmacy College, Gujarat Technological University, Gujarat, India, 2011: 7-28.
8. Pharmaceutical Drug Analysis. 2nd Ed. New Delhi: New Age International Publisher; 2005: 455-466.
9. Ahuja S, Michael WD. Hand book of Pharmaceutical Analysis by HPLC. 1st London: Elsevier Academic Press; 2005: 44-54.
10. Snyder LR, Kirkland JL, Glajch JL. Practical HPLC Method Development. 3rd Ed. New York: Wiley; 1988: 227.
11. Skoog DA, West DM. Principles of Instrumental Analysis. 2nd Ed. Saunders Golden Sunburst Series. Philadelphia; 1980: 674-675, 690-696.
12. Kealey and P.J Haines, Analytical Chemistry, 1^st edition, Bios Publisher, (2002), PP 1- 7.
13. BraithWait and F.J. Smith, Chromatographic Methods, 5^thedition, Kluwer Academic Publisher, (1996), PP 1-2.
14. Andrea Weston and Phyllisr. Brown, HPLC Principle and Practice,  1^st  edition, Academic press, (1997), PP 24-37.
15. Pemra Raju K. Thejomoorthy2, P. Sreenivasa Prasanna. Development and Validation of New Analytical Method for The Simultaneous Estimation of Darunavir and Ritonavir in Pharmaceutical Dosage Form. Int J Indig Herbs Drugs 2021;6(2):49-57.